Indian study: Atezolizumab-Bevacizumab combo in uHCC shows promising results, with tumour shrinkage and survival benefits, especially when coupled with early treatment and local radiation ... Sep 15
Britain's NHS leads with a pioneering seven-minute cancer treatment, cutting therapy time up to 75%. The injection, utilizing atezolizumab, promises substantial progress in ... Aug 31
Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
... Mar 05
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer.... Nov 02
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
DGCI approves new breast cancer medicine by Roche... Apr 10
First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ... Sep 10
-Advertisements-
Friday, June 14, 2024
